PARP inhibitors in gastric cancer: beacon of hope

por Wang, Yali, Zheng, Kun, Huang, Yongbiao, Xiong, Hua, Su, Jinfang, Chen, Rui, Zou, Yanmei
Publicado 2021

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma

por Su, Jinfang, Huang, Yongbiao, Wang, Yali, Li, Rui, Deng, Wanjun, Zhang, Hao, Xiong, Huihua
Publicado 2022

PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer

por Wang, Yali, Zheng, Kun, Xiong, Hua, Huang, Yongbiao, Chen, Xiuqiong, Zhou, Yilu, Qin, Wan, Su, Jinfang, Chen, Rui, Qiu, Hong, Yuan, Xianglin, Wang, Yihua, Zou, Yanmei
Publicado 2021